We strive to provide life-saving medicine
for people suffering from diseases,
including their families, around the world.
News
- Dec.20,2022 News release FIMECS Announces Yusuke Tominari, CEO is Received The Outstanding Leadership Award at the Health 2.0 Conference
1.75 KB
- Nov.15,2022 News release FIMECS Announces to be Awarded Second Prize at the KPMG Private Enterprise’s Global Tech Innovator 2022
- Oct.1,2022 News release FIMECS Presents at the 5th Targeted Protein Degradation Summit
1.11 KB
- Sep.28,2022 News release FIMECS Presents at The Protein Degradation & Targeting Undruggables Europe 2022 in Basel, Switzerland
1.11 KB
- Aug.5,2022 News release FIMECS Announces to be Awarded the First Prize at the KPMG Global Tech Innovator Competition in Japan 2022 and Invited for World Championship Held in Lisbon, Portugal in November
1.12 KB
- Mar.29,2022 News release FIMECS Announces Change of Directors
1.12 KB
- Feb.1,2022 News release FIMECS Announces Strategic Research Collaboration with Astellas to Discover Protein Degraders Against Multiple Targets
1.13 KB
- Jan.24,2022 News release FIMECS Announces 1,175 Million JPY (ca. 10.3 Million USD) Series B Financing to Advance its Protein Degrader Pipeline and Platform
1.13 KB
- Nov.9,2021 News release FIMECS was Awarded The Global Health Innovative Technology Fund
707.00 B
- Sep.13,2021 News release FIMECS Organizes Scientific Advisory Board
1.14 KB
- Aug.18,2021 News release FIMECS was Adopted 250M JPY of Grant Funding, “Product Commercialization Alliance (PCA)”
1.14 KB
- Feb.14,2021 News release FIMECS Presents at Virtual Symposium: Targeted Protein Degradation & PROTAC
1.15 KB
- Jan.21,2021 News release FIMECS is Named by The 2020 APAC Business Awards as “Best Tech-Based Drug Discovery Biotech – Japan”
1.15 KB
- Jan.1,2021 News release FIMECS Appoints Dr. Kanae Gamo as Chief Scientific Officer
1.16 KB
- Nov.12,2020 News release Publication about the AID2 technology as a collaboration with National Institute of Genetics
1.16 KB
- May.28,2020 News release FIMECS Announces Change of Directors
1.16 KB
- May.28,2020 News release Strategic Financing to Accelerate FIMECS Protein Degraders Drug Discovery
1.17 KB
- Oct.26,2019 News release FIMECS Presents IRAK-M Program for Immuno-Oncology at SITC 2019
1.17 KB
- Oct.8,2019 News release FIMECS is Named One of “TOP10 BIOTECH STARTUPS IN APAC-2019” Companies
1.18 KB
- Sep.9,2019 News release FIMECS Presents at 4 th Medicinal Chemistry & Protein Degradation Summit
1.18 KB
Read More
